Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru
Background The COVID-19 pandemic exposed vulnerabilities in health systems and revealed variations in immune responses across populations worldwide. This study examined the kinetics of IgG and IgM antibodies against S1 and receptor-binding domain (RBD) proteins in hospitalized Peruvian patients prio...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2025-08-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/19771.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849225515628494848 |
|---|---|
| author | Salyoc Tapia-Rojas Alexis Germán Murillo Carrasco Maria J. Pons Manuel Ugarte-Gil Ana Mayanga-Herrera |
| author_facet | Salyoc Tapia-Rojas Alexis Germán Murillo Carrasco Maria J. Pons Manuel Ugarte-Gil Ana Mayanga-Herrera |
| author_sort | Salyoc Tapia-Rojas |
| collection | DOAJ |
| description | Background The COVID-19 pandemic exposed vulnerabilities in health systems and revealed variations in immune responses across populations worldwide. This study examined the kinetics of IgG and IgM antibodies against S1 and receptor-binding domain (RBD) proteins in hospitalized Peruvian patients prior to vaccination. Method A total of 157 serological samples were collected from 44 hospitalized COVID-19 patients during Peru’s first wave (August–October 2020) and stored at −80 °C. Anti-SARS-CoV-2 IgG and IgM antibodies were quantified using an in-house ELISA with recombinant Spike S1 and RBD proteins. Statistical analyses—including linear regression, Kaplan-Meier curves, and receiver operating characteristic (ROC) curves—were conducted to evaluate antibody kinetics, clinical correlations, and predictive accuracy. Results IgG levels stabilized between days 10 and 15 of hospitalization, while IgM levels declined after day 10, with greater variability observed in severe acute respiratory distress syndrome (ARDS) cases. A significant positive correlation was found between IgG levels and lymphocyte counts (R = 0.37, p < 0.001), and a negative correlation with neutrophil counts (R = − 0.33, p < 0.01), particularly in severe ARDS non-ICU patients (R = − 0.34, p < 0.01). Severe ARDS cases also exhibited elevated neutrophil-to-lymphocyte ratios and increased inflammatory biomarkers, such as C-reactive protein and D-dimer, indicating an exacerbated inflammatory response associated with poorer prognosis. Risk factors, including sex and obesity, were linked to higher mortality and increased need for mechanical ventilation. This study contributes to a better understanding of the immune response in COVID-19 and supports the development of predictive models based on immunological and hematological biomarkers. |
| format | Article |
| id | doaj-art-e6d054a9efa64285a104667a914b0d54 |
| institution | Kabale University |
| issn | 2167-8359 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj-art-e6d054a9efa64285a104667a914b0d542025-08-24T15:05:14ZengPeerJ Inc.PeerJ2167-83592025-08-0113e1977110.7717/peerj.19771Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in PeruSalyoc Tapia-Rojas0Alexis Germán Murillo Carrasco1Maria J. Pons2Manuel Ugarte-Gil3Ana Mayanga-Herrera4Cancer and Stem Cells Research Group, Universidad Cientifica del Sur, Lima, PeruCentro de Investigação Translacional em Oncologia (LIM24), Departamento de Radiologia, Universidade de São Paulo, Sao Paulo, BrazilGrupo de Enfermedades Infecciosas Re-Emergentes, Universidad Cientifica del Sur, Lima, PeruGrupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Cientifica del Sur, Lima, PeruCancer and Stem Cells Research Group, Universidad Cientifica del Sur, Lima, PeruBackground The COVID-19 pandemic exposed vulnerabilities in health systems and revealed variations in immune responses across populations worldwide. This study examined the kinetics of IgG and IgM antibodies against S1 and receptor-binding domain (RBD) proteins in hospitalized Peruvian patients prior to vaccination. Method A total of 157 serological samples were collected from 44 hospitalized COVID-19 patients during Peru’s first wave (August–October 2020) and stored at −80 °C. Anti-SARS-CoV-2 IgG and IgM antibodies were quantified using an in-house ELISA with recombinant Spike S1 and RBD proteins. Statistical analyses—including linear regression, Kaplan-Meier curves, and receiver operating characteristic (ROC) curves—were conducted to evaluate antibody kinetics, clinical correlations, and predictive accuracy. Results IgG levels stabilized between days 10 and 15 of hospitalization, while IgM levels declined after day 10, with greater variability observed in severe acute respiratory distress syndrome (ARDS) cases. A significant positive correlation was found between IgG levels and lymphocyte counts (R = 0.37, p < 0.001), and a negative correlation with neutrophil counts (R = − 0.33, p < 0.01), particularly in severe ARDS non-ICU patients (R = − 0.34, p < 0.01). Severe ARDS cases also exhibited elevated neutrophil-to-lymphocyte ratios and increased inflammatory biomarkers, such as C-reactive protein and D-dimer, indicating an exacerbated inflammatory response associated with poorer prognosis. Risk factors, including sex and obesity, were linked to higher mortality and increased need for mechanical ventilation. This study contributes to a better understanding of the immune response in COVID-19 and supports the development of predictive models based on immunological and hematological biomarkers.https://peerj.com/articles/19771.pdfCOVID-19AntibodiesKineticsImmunityHospitalizationPeru |
| spellingShingle | Salyoc Tapia-Rojas Alexis Germán Murillo Carrasco Maria J. Pons Manuel Ugarte-Gil Ana Mayanga-Herrera Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru PeerJ COVID-19 Antibodies Kinetics Immunity Hospitalization Peru |
| title | Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru |
| title_full | Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru |
| title_fullStr | Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru |
| title_full_unstemmed | Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru |
| title_short | Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru |
| title_sort | kinetics of anti sars cov 2 antibodies and hematological parameters in hospitalized pre vaccination covid 19 patients in peru |
| topic | COVID-19 Antibodies Kinetics Immunity Hospitalization Peru |
| url | https://peerj.com/articles/19771.pdf |
| work_keys_str_mv | AT salyoctapiarojas kineticsofantisarscov2antibodiesandhematologicalparametersinhospitalizedprevaccinationcovid19patientsinperu AT alexisgermanmurillocarrasco kineticsofantisarscov2antibodiesandhematologicalparametersinhospitalizedprevaccinationcovid19patientsinperu AT mariajpons kineticsofantisarscov2antibodiesandhematologicalparametersinhospitalizedprevaccinationcovid19patientsinperu AT manuelugartegil kineticsofantisarscov2antibodiesandhematologicalparametersinhospitalizedprevaccinationcovid19patientsinperu AT anamayangaherrera kineticsofantisarscov2antibodiesandhematologicalparametersinhospitalizedprevaccinationcovid19patientsinperu |